Showing results (121-130 of 161) with videos related to

Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|October 29, 2000
A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusionJ G Supko, T J Lynch, J W Clark, et al.
International Journal of Cancer|August 15, 1984
Type-I HTLV antibody in urban and rural Ghana, West AfricaR J Biggar, C Saxinger, C Gardiner, et al.
Lasers in Surgery and Medicine|January 1, 1989
Comparative study of suture and laser-assisted anastomoses in rat sciatic nervesT A Benke, J W Clark, P J Wisoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
The in vivo immunomodulatory effects of recombinant interferon gamma plus recombinant tumor necrosis factor-alfaW J Urba, W C Kopp, J W Clark, et al.
British Journal of Cancer|November 27, 1999
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasisJ W Clark, L Snell, R P Shiu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2006
Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?D Strumberg, A Awada, H Hirte, et al.
Journal of the American Dental Association (1939)|September 1, 1986
Intraoral effects of a fluoride-releasing device on acid-softened enamelR E Corpron, J W Clark, A Tsai, et al.
The New England Journal of Medicine|June 2, 1988
Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodiesR G Steis, J W Smith, W J Urba, et al.
AJNR. American Journal of Neuroradiology|January 1, 1987
Chemonucleation and changes observed on lumbar MR scan: preliminary reportM S Huckman, J W Clark, T W McNeill, et al.
Pageof 17